Skip to main content
. 2020 Nov 28;8(12):547. doi: 10.3390/biomedicines8120547

Figure 2.

Figure 2

Oxidation of cabozantinib by human recombinant CYPs. Value represents mean ± SD of three independent in vitro incubations (n = 3). *** p < 0.001 significant differences between the formation of individual metabolites by CYP enzymes with and without cytochrome b5 (b5). ND—not detected.